Perci Health, one of the UK’s most comprehensive virtual cancer clinics, has secured £7.7 million in total funding after closing a new £3 million investment round, doubling its initial target. This latest round included a £295,000 investment from Macmillan Cancer Support, underscoring the charity’s strong belief in Perci Health’s mission to transform cancer care. Existing investors Octopus Ventures, alongside Guinness Ventures and Conduit Fund, joined forces with 35 leading UK oncologists and surgeons to back the company.
Founded by healthcare innovators Kelly McCabe and Morgan Fitzsimons, Perci Health combines AI technology with expert care from a multidisciplinary team of nurses, dietitians, physiotherapists, and psychologists. Their holistic model supports people impacted by cancer throughout prevention, treatment, and recovery, aiming to deliver life-changing outcomes for patients and families.
With 100% of its directors and a majority of its leadership composed of women, Perci Health stands out as a rare female-led scale-up in the UK, having raised twice the average deal size for female-founded startups in each funding round. CEO Kelly McCabe highlights that this investment will help the company pioneer a compassionate, tech-enabled model of care that integrates digital innovation with specialist-led support.
The need for such services is growing as nearly 3.5 million people live with cancer in the UK, many of whom require ongoing support to stay in or return to work after treatment. Perci Health addresses gaps in early detection, treatment navigation, symptom management, and survivorship care, especially amid late-stage cancer diagnoses and missed screening appointments in the UK.
The funding will also accelerate partnerships with employers and insurers, expanding access to Perci Health’s services. This growth aligns with government priorities on vocational rehabilitation and reducing long-term sickness absence, with Perci Health enabling earlier intervention and personalized recovery plans tailored to the complex needs of cancer patients.
Investors praise Perci Health’s innovative, scalable model for delivering measurable clinical outcomes and cost efficiency. Macmillan Cancer Support emphasizes the importance of holistic care in improving quality of life for people living with and beyond cancer.
Perci Health aims to improve global cancer outcomes through a digital, AI-native platform that delivers supportive cancer care at scale. With a growing team of over 85 specialists, the company is positioned to reshape cancer survivorship care for better patient outcomes and economic sustainability.
Follow MEDWIRE.AI for innovations in cancer care and health technology.
